Below are the most recent publications written about "Glioma" by people in Profiles.
-
McIlvain G, Hayes LL, Walter AW, Averill LW, Kandula V, Johnson CL, Nikam RM. Mechanical properties of pediatric low-grade gliomas in children with and without neurofibromatosis type 1. Neuroradiology. 2024 Dec; 66(12):2301-2311.
-
Alnahhas I. Molecular Testing in Gliomas: What is Necessary in Routine Clinical Practice? Curr Oncol Rep. 2024 Nov; 26(11):1277-1282.
-
Das S, Ahlawat S, Panda AK, Sarangi J, Jain P, Gupta RK, Vaishya S, Patir R. Pediatric high grade gliomas: A comprehensive histopathological, immunohistochemical and molecular integrated approach in routine practice. Pathol Res Pract. 2024 Jun; 258:155347.
-
Ramakrishnan D, Br?ningk SC, von Reppert M, Memon F, Maleki N, Aneja S, Kazerooni AF, Nabavizadeh A, Lin M, Bousabarah K, Molinaro A, Nicolaides T, Prados M, Mueller S, Aboian MS. Comparison of Volumetric and 2D Measurements and Longitudinal Trajectories in the Response Assessment of BRAF V600E-Mutant Pediatric Gliomas in the Pacific Pediatric Neuro-Oncology Consortium Clinical Trial. AJNR Am J Neuroradiol. 2024 04 08; 45(4):475-482.
-
Shi W, Palmer JD, Alnahhas I. Emerging insights on management of high-grade glioma. Chin Clin Oncol. 2024 Feb; 13(1):1.
-
Tillmanns N, Lost J, Tabor J, Vasandani S, Vetsa S, Marianayagam N, Yalcin K, Erson-Omay EZ, von Reppert M, Jekel L, Merkaj S, Ramakrishnan D, Avesta A, de Oliveira Santo ID, Jin L, Huttner A, Bousabarah K, Ikuta I, Lin M, Aneja S, Turowski B, Aboian M, Moliterno J. Application of novel PACS-based informatics platform to identify imaging based predictors of CDKN2A allelic status in glioblastomas. Sci Rep. 2023 12 22; 13(1):22942.
-
DesJarlais AM, Miller R, Ali AS, Niazi MZ, Cappelli L, Glass J, Farrell CJ, Shi W. Case report: durable response of gliomatosis cerebri with concurrent tumor-treating fields (TTFields) and chemoradiotherapy treatment. Chin Clin Oncol. 2023 Dec; 12(6):69.
-
Lost J, Verma T, Jekel L, von Reppert M, Tillmanns N, Merkaj S, Petersen GC, Bahar R, Gordem A, Haider MA, Subramanian H, Brim W, Ikuta I, Omuro A, Conte GM, Marquez-Nostra BV, Avesta A, Bousabarah K, Nabavizadeh A, Kazerooni AF, Aneja S, Bakas S, Lin M, Sabel M, Aboian M. Systematic Literature Review of Machine Learning Algorithms Using Pretherapy Radiologic Imaging for Glioma Molecular Subtype Prediction. AJNR Am J Neuroradiol. 2023 10; 44(10):1126-1134.
-
Lee MD, Patel SH, Mohan S, Akbari H, Bakas S, Nasrallah MP, Calabrese E, Rudie J, Villanueva-Meyer J, LaMontagne P, Marcus DS, Colen RR, Balana C, Choi YS, Badve C, Barnholtz-Sloan JS, Sloan AE, Booth TC, Palmer JD, Dicker AP, Flanders AE, Shi W, Griffith B, Poisson LM, Chakravarti A, Mahajan A, Chang S, Orringer D, Davatzikos C, Jain R. Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium. Neuroradiology. 2023 Sep; 65(9):1343-1352.
-
Gubbiotti MA, Dhillon KS, Harris J, Kothari S, Ware JB, Desai A, Shabason J, Miettinen M, Quezado M, Aldape K, Judy K, Wang ZX, Curtis MT, Nasrallah MP. An unusual case of metastatic diffuse midline glioma in an adult. J Neuropathol Exp Neurol. 2023 06 20; 82(7):659-663.